Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB

Therapeutic drug monitoring for drug-resistant tuberculosis (TB) is likely to improve treatment outcomes. While assessments of plasma drug levels can explain pharmacokinetic variability among trial participants, these measures require phlebotomy and a cold chain, and are generally not repeated frequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Metcalfe, John, Bacchetti, Peter, Gerona, Roy, Esmail, Ali, Dheda, Keertan, Gandhi, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484095/
https://www.ncbi.nlm.nih.gov/pubmed/31041318
http://dx.doi.org/10.1183/23120541.00046-2019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484095/
https://www.ncbi.nlm.nih.gov/pubmed/31041318
http://dx.doi.org/10.1183/23120541.00046-2019

Ejemplares similares